| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | rofecoxib | FAERS: 3 | US FAERS | |
| 2 | Bupivacaine | FAERS: 2 | US FAERS | |
| 3 | Isotretinoin | FAERS: 2 | US FAERS | |
| 4 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 5 | Atorvastatin | FAERS: 1 | US FAERS | |
| 6 | Dasatinib | FAERS: 1 | US FAERS | |
| 7 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 8 | Sorafenib | FAERS: 1 | US FAERS | |
| 9 | Topiramate | FAERS: 1 | US FAERS | |
| 10 | Vincristine | FAERS: 1 | US FAERS | |
| 11 | Bortezomib | SIDER | ||
| 12 | Citalopram | SIDER | ||
| 13 | Ibandronic Acid | SIDER | ||
| 14 | ropinirole | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.